1328 ET - Altria Chief Executive Billy Gifford said he hopes job cuts at the FDA will come with a review of the organization's processes to improve efficiency. Jim Jones, the FDA's deputy commissioner for human foods, resigned Monday, citing dozens of layoffs since Trump took office. In a conference presentation Wednesday, Gifford emphasized the need for FDA approval of e-vapor products as Altria aims to make its NJOY e-cigarette business profitable. The CEO said there is a significant demand for smoke-free alternatives, but Altria is struggling to meet it due to regulatory barriers. "In the absence of FDA authorization of flavored product choices, consumers have turned to the illicit flavored disposable market," Gifford said. (katherine.hamilton@wsj.com)
(END) Dow Jones Newswires
February 19, 2025 13:28 ET (18:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。